Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its access have become key concerns for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its expensive nature presents a significant barrier to many.